The Verigene® Respiratory Pathogens Flex Nucleic Acid Test (RP Flex) is a mult
The Verigene® Respiratory Pathogens Flex Nucleic Acid Test (RP Flex) is a multiplexed qualitative test intended for the simultaneous detection and identification of multiple viral and bacterial nucleic acids in nasopharyngeal swabs (NPS) obtained from individuals suspected of respiratory tract infection.
OZE,OEM,OCC,OEP,OZZ,OOU
Influenza A And Influenza B Multiplex Nucleic Acid Assay,Human Metapneumovirus (
Influenza A And Influenza B Multiplex Nucleic Acid Assay,Human Metapneumovirus (Hmpv) Rna Assay System,Respiratory Virus Panel Nucleic Acid Assay System,Influenza A Virus Subtype Differentiation Nucleic Acid Assay,Bordetella Pertussis Dna Assay System,Parainfluenza Multiplex Nucleic Acid Assay
2
Respiratory Pathogens Flex (RP Flex) Nucleic Acid Test Cartridge
The Verigene® Enteric Pathogens Nucleic Acid Test (EP) is a multiplexed, quali
The Verigene® Enteric Pathogens Nucleic Acid Test (EP) is a multiplexed, qualitative test for simultaneous detection and identification of common pathogenic enteric bacteria, viruses, and genetic virulence markers from liquid or soft stool preserved in Cary-Blair medium, collected from individuals with signs and symptoms of gastrointestinal infection.
The Verigene® Respiratory Pathogens Flex Nucleic Acid Test (RP Flex) is a mult
The Verigene® Respiratory Pathogens Flex Nucleic Acid Test (RP Flex) is a multiplexed qualitative test intended for the simultaneous detection and identification of multiple viral and bacterial nucleic acids in nasopharyngeal swabs (NPS) obtained from individuals suspected of respiratory tract infection.
OZE,OEM,OCC,OEP,OZZ,OOU
Influenza A And Influenza B Multiplex Nucleic Acid Assay,Human Metapneumovirus (
Influenza A And Influenza B Multiplex Nucleic Acid Assay,Human Metapneumovirus (Hmpv) Rna Assay System,Respiratory Virus Panel Nucleic Acid Assay System,Influenza A Virus Subtype Differentiation Nucleic Acid Assay,Bordetella Pertussis Dna Assay System,Parainfluenza Multiplex Nucleic Acid Assay
The Verigene® Respiratory Virus Plus Nucleic Acid Test (RV+) on the Verigene
The Verigene® Respiratory Virus Plus Nucleic Acid Test (RV+) on the Verigene® System is a qualitative nucleic acid multiplex test intended to simultaneously detect and identify multiple respiratory virus nucleic acids in nasopharyngeal (NP) swab specimens from individuals with signs and symptoms of respiratory tract infection.
The Verigene® Processor SP is an instrument which integrates sample preparation,
The Verigene® Processor SP is an instrument which integrates sample preparation, target amplification, and target hybridization within a single device as part of the Verigene® System, a benchtop molecular diagnostics workstation that utilizes patented gold nanoparticle technology to detect nucleic acid targets of interest for a variety of applications.
OOI,NSU
Real Time Nucleic Acid Amplification System,Instrumentation For Clinical Multipl
Real Time Nucleic Acid Amplification System,Instrumentation For Clinical Multiplex Test Systems
The Verigene® Reader is the central control of the Verigene® System, a benchtop
The Verigene® Reader is the central control of the Verigene® System, a benchtop molecular diagnostics workstation that utilizes patented gold nanoparticle technology to detect nucleic acid targets of interest for a variety of applications. (Refurbished)
NSU,OOI
Instrumentation For Clinical Multiplex Test Systems,Real Time Nucleic Acid Ampli
Instrumentation For Clinical Multiplex Test Systems,Real Time Nucleic Acid Amplification System
The Verigene® Clostridium difficile Nucleic Acid Test (CDF) is a qualitative m
The Verigene® Clostridium difficile Nucleic Acid Test (CDF) is a qualitative multiplexed in vitro diagnostic test for the rapid detection of toxin A (tcdA), toxin B (tcdB), and tcdC gene sequences of toxigenic Clostridium difficile and for presumptive identification of PCR ribotype 027 strains from unformed (liquid or soft) stool specimens collected from patients suspected of having C. difficile infection (CDI).
The Verigene® Gram-Negative Blood Culture Nucleic Acid Test (BC-GN) performed
The Verigene® Gram-Negative Blood Culture Nucleic Acid Test (BC-GN) performed using the sample-to-result Verigene® System, is a qualitative multiplexed in vitro diagnostic test for the simultaneous detection and identification of selected gram-negative bacteria and resistance markers.
PEN
Gram-Negative Bacteria And Associated Resistance Markers
The Verigene® Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) performed us
The Verigene® Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) performed using the sample-to-result Verigene® System is a qualitative, multiplexed in vitro diagnostic test for the simultaneous detection and identification of potentially pathogenic gram-positive bacteria which may cause bloodstream infection (BSI).
NQX,PAM
System, Nucleic Acid Amplification Test, Dna, Methicillin Resistant Staphylococc
System, Nucleic Acid Amplification Test, Dna, Methicillin Resistant Staphylococcus Aureus, Direct Specimen,Gram-Positive Bacteria And Their Resistance Markers
The Verigene® Respiratory Virus Plus Nucleic Acid Test (RV+) on the Verigene
The Verigene® Respiratory Virus Plus Nucleic Acid Test (RV+) on the Verigene® System is a qualitative nucleic acid multiplex test intended to simultaneously detect and identify multiple respiratory virus nucleic acids in nasopharyngeal (NP) swab specimens from individuals with signs and symptoms of respiratory tract infection.
OCC
Respiratory Virus Panel Nucleic Acid Assay System
2
Respiratory Virus Plus (RV+) Nucleic Acid Test Cartridge
The Verigene® Gram-Negative Blood Culture Nucleic Acid Test (BC-GN) performed us
The Verigene® Gram-Negative Blood Culture Nucleic Acid Test (BC-GN) performed using the sample-to-result Verigene® System, is a qualitative multiplexed in vitro diagnostic test for the simultaneous detection and identification of selected gram-negative bacteria and resistance markers.
PEN
Gram-Negative Bacteria And Associated Resistance Markers
2
Gram-Negative Blood Culture (BC-GN) Nucleic Acid Test Cartridge
The Verigene® Processor SP is an instrument which integrates sample preparation,
The Verigene® Processor SP is an instrument which integrates sample preparation, target amplification, and target hybridization within a single device as part of the Verigene® System, a benchtop molecular diagnostics workstation that utilizes patented gold nanoparticle technology to detect nucleic acid targets of interest for a variety of applications. (Refurbished)
NSU,OOI
Instrumentation For Clinical Multiplex Test Systems,Real Time Nucleic Acid Ampli
Instrumentation For Clinical Multiplex Test Systems,Real Time Nucleic Acid Amplification System
The Verigene® Hypercoagulation Panel Nucleic Acid Test contains the Verigene®
The Verigene® Hypercoagulation Panel Nucleic Acid Test contains the Verigene® F5 Nucleic Acid Test, the Verigene® F2 Nucleic Acid Test and the Verigene® MTHFR Nucleic Acid Test. The Verigene® F5 Nucleic Acid Test is an in vitro diagnostic for the detection and genotyping of a single point mutation (G to A at position 1691; also known as Factor V Leiden) of the human Factor V gene (F5; Coagulation Factor V gene) in patients with suspected thrombophilia, from isolated genomic DNA obtained from whole blood samples. The Verigene® F2 Nucleic Acid Test is an in vitro diagnostic for the detection and genotyping of a single point mutation (G to A at position 20210) of the human Factor II gene (F2; prothrombin gene) in patients with suspected thrombophilia, from isolated genomic DNA obtained from whole blood samples. The Verigene® MTHFR Nucleic Acid Test is an in vitro diagnostic for the detection and genotyping of a single point mutation (C to T at position 677) of the human 5,10 methylenetetrahydrofolate reductase gene (MTHFR) in patients with suspected thrombophilia, from isolated genomic DNA obtained from whole blood samples.
NPQ,OMM,NPR
Test, Factor V Leiden Mutations, Genomic Dna Pcr,Test 5, 10-Methylenetetrahydrof
Test, Factor V Leiden Mutations, Genomic Dna Pcr,Test 5, 10-Methylenetetrahydrofolate Reductase Mutations, Genomic Dna Pcr,Test, Factor Ii G20210a Mutations, Genomic Dna Pcr
The Verigene® Clostridium difficile Nucleic Acid Test (CDF) is a qualitative m
The Verigene® Clostridium difficile Nucleic Acid Test (CDF) is a qualitative multiplexed in vitro diagnostic test for the rapid detection of toxin A (tcdA), toxin B (tcdB), and tcdC gene sequences of toxigenic Clostridium difficile and for presumptive identification of PCR ribotype 027 strains from unformed (liquid or soft) stool specimens collected from patients suspected of having C. difficile infection (CDI).
The Verigene® Respiratory Virus Plus Nucleic Acid Test (RV+) on the Verigene®
The Verigene® Respiratory Virus Plus Nucleic Acid Test (RV+) on the Verigene® System is a qualitative nucleic acid multiplex test intended to simultaneously detect and identify multiple respiratory virus nucleic acids in nasopharyngeal (NP) swab specimens from individuals with signs and symptoms of respiratory tract infection.
The Verigene® Enteric Pathogens Nucleic Acid Test (EP) is a multiplexed, quali
The Verigene® Enteric Pathogens Nucleic Acid Test (EP) is a multiplexed, qualitative test for simultaneous detection and identification of common pathogenic enteric bacteria, viruses, and genetic virulence markers from liquid or soft stool preserved in Cary-Blair medium, collected from individuals with signs and symptoms of gastrointestinal infection.
The Verigene® Gram-Negative Blood Culture Nucleic Acid Test (BC-GN) performed us
The Verigene® Gram-Negative Blood Culture Nucleic Acid Test (BC-GN) performed using the sample-to-result Verigene® System, is a qualitative multiplexed in vitro diagnostic test for the simultaneous detection and identification of selected gram-negative bacteria and resistance markers.
PEN
Gram-Negative Bacteria And Associated Resistance Markers
The Verigene® Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) performed us
The Verigene® Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) performed using the sample-to-result Verigene® System is a qualitative, multiplexed in vitro diagnostic test for the simultaneous detection and identification of potentially pathogenic gram-positive bacteria which may cause bloodstream infection (BSI).
NQX,PAM
System, Nucleic Acid Amplification Test, Dna, Methicillin Resistant Staphylococc
System, Nucleic Acid Amplification Test, Dna, Methicillin Resistant Staphylococcus Aureus, Direct Specimen,Gram-Positive Bacteria And Their Resistance Markers
The Verigene® Hypercoagulation Panel Nucleic Acid Test contains the Verigene®
The Verigene® Hypercoagulation Panel Nucleic Acid Test contains the Verigene® F5 Nucleic Acid Test, the Verigene® F2 Nucleic Acid Test and the Verigene® MTHFR Nucleic Acid Test. The Verigene® F5 Nucleic Acid Test is an in vitro diagnostic for the detection and genotyping of a single point mutation (G to A at position 1691; also known as Factor V Leiden) of the human Factor V gene (F5; Coagulation Factor V gene) in patients with suspected thrombophilia, from isolated genomic DNA obtained from whole blood samples. The Verigene® F2 Nucleic Acid Test is an in vitro diagnostic for the detection and genotyping of a single point mutation (G to A at position 20210) of the human Factor II gene (F2; prothrombin gene) in patients with suspected thrombophilia, from isolated genomic DNA obtained from whole blood samples. The Verigene® MTHFR Nucleic Acid Test is an in vitro diagnostic for the detection and genotyping of a single point mutation (C to T at position 677) of the human 5,10 methylenetetrahydrofolate reductase gene (MTHFR) in patients with suspected thrombophilia, from isolated genomic DNA obtained from whole blood samples.
NPQ,OMM,NPR
Test, Factor V Leiden Mutations, Genomic Dna Pcr,Test 5, 10-Methylenetetrahydrof
Test, Factor V Leiden Mutations, Genomic Dna Pcr,Test 5, 10-Methylenetetrahydrofolate Reductase Mutations, Genomic Dna Pcr,Test, Factor Ii G20210a Mutations, Genomic Dna Pcr
2
Hypercoagulation Panel (HC) Nucleic Acid Test Cartridge
The Verigene® Reader is the central control of the Verigene® System, a benchtop
The Verigene® Reader is the central control of the Verigene® System, a benchtop molecular diagnostics workstation that utilizes patented gold nanoparticle technology to detect nucleic acid targets of interest for a variety of applications.
OOI,NSU
Real Time Nucleic Acid Amplification System,Instrumentation For Clinical Multipl
Real Time Nucleic Acid Amplification System,Instrumentation For Clinical Multiplex Test Systems
The Verigene® Processor is an instrument which internalizes all of the functions
The Verigene® Processor is an instrument which internalizes all of the functions required to process a Test Cartridge as part of the Verigene® System, a benchtop molecular diagnostics workstation that utilizes patented gold nanoparticle technology to detect nucleic acid targets of interest for a variety of applications.
NSU
Instrumentation For Clinical Multiplex Test Systems
The Verigene® Clostridium difficile Nucleic Acid Test (CDF) is a qualitative m
The Verigene® Clostridium difficile Nucleic Acid Test (CDF) is a qualitative multiplexed in vitro diagnostic test for the rapid detection of toxin A (tcdA), toxin B (tcdB), and tcdC gene sequences of toxigenic Clostridium difficile and for presumptive identification of PCR ribotype 027 strains from unformed (liquid or soft) stool specimens collected from patients suspected of having C. difficile infection (CDI).
The Verigene® Clostridium difficile Nucleic Acid Test (CDF) is a qualitative mul
The Verigene® Clostridium difficile Nucleic Acid Test (CDF) is a qualitative multiplexed in vitro diagnostic test for the rapid detection of toxin A (tcdA), toxin B (tcdB), and tcdC gene sequences of toxigenic Clostridium difficile and for presumptive identification of PCR ribotype 027 strains from unformed (liquid or soft) stool specimens collected from patients suspected of having C. difficile infection (CDI).
OZN
C.Difficile Toxin Gene Amplification Assay
2
Clostridium difficile (CDF) Nucleic Acid Test Cartridge
The Verigene® Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) performed
The Verigene® Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) performed using the sample-to-result Verigene® System is a qualitative, multiplexed in vitro diagnostic test for the simultaneous detection and identification of potentially pathogenic gram-positive bacteria which may cause bloodstream infection (BSI).
NQX,PAM
System, Nucleic Acid Amplification Test, Dna, Methicillin Resistant Staphylococc
System, Nucleic Acid Amplification Test, Dna, Methicillin Resistant Staphylococcus Aureus, Direct Specimen,Gram-Positive Bacteria And Their Resistance Markers
2
Gram-Positive Blood Culture (BC-GP) Nucleic Acid Test Cartridge
The Verigene® Enteric Pathogens Nucleic Acid Test (EP) is a multiplexed, quali
The Verigene® Enteric Pathogens Nucleic Acid Test (EP) is a multiplexed, qualitative test for simultaneous detection and identification of common pathogenic enteric bacteria, viruses, and genetic virulence markers from liquid or soft stool preserved in Cary-Blair medium, collected from individuals with signs and symptoms of gastrointestinal infection.
The Verigene® Enteric Pathogens Nucleic Acid Test (EP) is a multiplexed, qualita
The Verigene® Enteric Pathogens Nucleic Acid Test (EP) is a multiplexed, qualitative test for simultaneous detection and identification of common pathogenic enteric bacteria, viruses, and genetic virulence markers from liquid or soft stool preserved in Cary-Blair medium, collected from individuals with signs and symptoms of gastrointestinal infection.
The Accula™ Flu A / B Control Kit is intended for in vitro diagnostic use in qua
The Accula™ Flu A / B Control Kit is intended for in vitro diagnostic use in qualitycontrol testing with the Accula™ Flu A / B Test.
The Accula™ Flu A / B Test performed on the Accula Dock is a molecular in vitro
The Accula™ Flu A / B Test performed on the Accula Dock is a molecular in vitro diagnostic test utilizing polymerasechain reaction (PCR) and lateral flow technology for the qualitative, visual detection and differentiation of influenza A andinfluenza B viral RNA. The Accula Flu A / B Test uses a nasal swab specimen collected from patients with signs andsymptoms of respiratory infection. Accula Flu A / B assay is intended as an aid in the diagnosis of influenza infectionsin conjunction with clinical and epidemiological risk factors. The assay is not intended to detect the presence of influenzaC virus.
The Programming Cassette is an accessory to the Accula Dock and facilitates repr
The Programming Cassette is an accessory to the Accula Dock and facilitates reprogramming of the Dock’s embedded firmware. When firmware updates are needed, the firmware will be stored onto Programming Cassettes and sent to end users, who will load the Programming Cassette into their Dock and re-program its firmware
The Programming Cassette is an accessory to the Accula Dock and facilitates repr
The Programming Cassette is an accessory to the Accula Dock and facilitates reprogramming of the Dock’s embedded firmware. When firmware updates are needed, the firmware will be stored onto Programming Cassettes and sent to end users, who will load the Programming Cassette into their Dock and re-program its firmware
The Accula Dock is an electronic module which executes in vitro diagnostic tests
The Accula Dock is an electronic module which executes in vitro diagnostic tests on compatible Test Cassettes. It consists of anelectro-mechanical interface to a single Test Cassette. The Dock contains all electrical systems, controls and logic necessary toorchestrate in-vitro diagnostic tests within the inserted Test Cassette.
The Accula Dock is an electronic module which executes in vitro diagnostic tests
The Accula Dock is an electronic module which executes in vitro diagnostic tests on compatible Test Cassettes. It consists of anelectro-mechanical interface to a single Test Cassette. The Dock contains all electrical systems, controls and logic necessary toorchestrate in-vitro diagnostic tests within the inserted Test Cassette.
The Silaris™ RSV Test performed on the Silaris™ Dock is a molecular in vitro dia
The Silaris™ RSV Test performed on the Silaris™ Dock is a molecular in vitro diagnostic test utilizing polymerase chainreaction (PCR) and lateral flow technologies for the qualitative, visual detection of respiratory syncytial virus (RSV) viral RNA.The Silaris RSV Test uses a nasal swab specimen collected from patients with signs and symptoms of respiratory infection.The Silaris RSV Test is intended as an aid in the diagnosis of RSV infection in children and adults in conjunction with clinicaland epidemiological risk factors.
The Silaris™ Influenza A&B Test performed on the Silaris Dock is a molecular in
The Silaris™ Influenza A&B Test performed on the Silaris Dock is a molecular in vitro diagnostic test utilizing polymerasechain reaction (PCR) and lateral flow technology for the qualitative, visual detection and differentiation of influenza A andinfluenza B viral RNA. The Silaris Influenza A&B Test uses a nasal swab specimen collected from patients with signs andsymptoms of respiratory infection. Silaris Influenza A&B assay is intended as an aid in the diagnosis of influenza infectionsin conjunction with clinical and epidemiological risk factors. The assay is not intended to detect the presence of influenzaC virus.
The Silaris RSV Control Kit is intended for in vitro diagnostic use in quality c
The Silaris RSV Control Kit is intended for in vitro diagnostic use in quality control testing with the Silaris RSV Test
The Silaris Starter Pack contains two (2) Silaris Influenza A&B kits and one (1)
The Silaris Starter Pack contains two (2) Silaris Influenza A&B kits and one (1) Silaris Dock for the purposes of starting up a clinical location.
The Silaris Starter Pack contains two (2) Silaris Influenza A&B kits and one (1)
The Silaris Starter Pack contains two (2) Silaris Influenza A&B kits and one (1) Silaris Dock for the purposes of starting up a clinical location.
The Silaris™ Influenza A&B Test performed on the Silaris Dock is a molecular in
The Silaris™ Influenza A&B Test performed on the Silaris Dock is a molecular in vitro diagnostic test utilizing polymerasechain reaction (PCR) and lateral flow technology for the qualitative, visual detection and differentiation of influenza A andinfluenza B viral RNA. The Silaris Influenza A&B Test uses a nasal swab specimen collected from patients with signs andsymptoms of respiratory infection. Silaris Influenza A&B assay is intended as an aid in the diagnosis of influenza infectionsin conjunction with clinical and epidemiological risk factors. The assay is not intended to detect the presence of influenzaC virus.
The Silaris Dock is an electronic module which executes in vitro diagnostic test
The Silaris Dock is an electronic module which executes in vitro diagnostic tests on compatible Silaris Test Cassettes. It consists of anelectro-mechanical interface to a single Test Cassette. The Dock contains all electrical systems, controls and logic necessary toorchestrate in-vitro diagnostic tests within the inserted Test Cassette.
The Silaris™ Influenza A&B Control Kit is intended for in vitro diagnostic use i
The Silaris™ Influenza A&B Control Kit is intended for in vitro diagnostic use in qualitycontrol testing with the Silaris™ Influenza A&B Test.